Eumark Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 17-11-2024
- Paid Up Capital ₹ 0.20 M
as on 17-11-2024
- Company Age 40 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.14 Cr
as on 17-11-2024
- Revenue -2.14%
(FY 2023)
- Profit -56.99%
(FY 2023)
- Ebitda -46.44%
(FY 2023)
- Net Worth 17.26%
(FY 2023)
- Total Assets 27.18%
(FY 2023)
About Eumark Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹2.14 Cr.
Bhooshan Pai and Karuna Pai serve as directors at the Company.
- CIN/LLPIN
U24230MH1984PTC032534
- Company No.
032534
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 1984
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Eumark Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhooshan Pai  | Director | 30-Mar-1984 | Current |
| Karuna Pai | Director | 31-Jul-2003 | Current |
Financial Performance of Eumark Pharmaceuticals.
Eumark Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.14% decrease. The company also saw a substantial fall in profitability, with a 56.99% decrease in profit. The company's net worth Soared by an impressive increase of 17.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eumark Pharmaceuticals?
In 2023, Eumark Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Saraswat Co-Operative Bank Ltd. Creation Date: 10 Dec 2014 | ₹6.00 M | Open |
Electronica Finance Limited Creation Date: 17 Sep 2014 | ₹1.86 M | Open |
Electronica Finance Limited Creation Date: 17 Sep 2014 | ₹1.22 M | Open |
How Many Employees Work at Eumark Pharmaceuticals?
Eumark Pharmaceuticals has a workforce of 24 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eumark Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eumark Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
